Insider Trading › ONVO › Insiders
ONVO
ONVO·Insider activity
—
No end-of-day price on record
ONVO
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
ONVOS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
No open-market insider purchases or sales of ONVO were filed in the last 180 days. Newest filing Nov 17, 2023 (2 years ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by ONVO insiders · Form 4 · last two years
No open-market insider buys or sells in the last two years.
On Record
$0Purchases · 180 days
$0Sales · 180 days
40Open-market transactions on record
0Insiders filing · 180 days
Purchases (code P) and sales (code S) of ONVO common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
40 on record · newest trade first
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| Gobel DavidDirector | Sale | −19.6K | $1.62 | $32K | 0direct | Nov 15, 2023 | Nov 17, 2023 | Form 4 ↗ |
| Gobel DavidDirector | Sale | −145 | $5.29 | $767 | 0direct | Nov 19, 2021 | Jul 8, 2022 | Form 4 ↗ |
| Cohen Douglas JayDirector | Purchase | +1,000 | $6.72 | $7K | 1,000indirect | Aug 17, 2021 | Aug 19, 2021 | Form 4 ↗ |
| Cohen Douglas JayDirector | Purchase | +1,000 | $6.74 | $7K | 1,000indirect | Aug 17, 2021 | Aug 19, 2021 | Form 4 ↗ |
| Cohen Douglas JayDirector | Purchase | +8,750 | $6.72 | $59K | 10.0Kdirect | Aug 17, 2021 | Aug 19, 2021 | Form 4 ↗ |
| Hughes Steven GeorgeChief Medical Officer | Sale | −22.2K | $0.29 | $6K | 138.5Kdirect | Aug 16, 2019 | Aug 19, 2019 | Form 4 ↗ |
| Presnell Sharon CollinsChief Scientific Officer | Sale | −40.0K | $1.27 | $51K | 292.2Kdirect | Nov 8, 2018 | Nov 13, 2018 | Form 4 ↗ |
| Murphy Keith | Purchase | +200.5K | $1.49 | $299K | 6.4Mdirect | Nov 24, 2017 | Dec 4, 2017 | Form 4 ↗ |
| Murphy Keith | Purchase | +135.0K | $1.50 | $203K | 6.2Mdirect | Nov 22, 2017 | Dec 4, 2017 | Form 4 ↗ |
| Murphy KeithChairman, CEO and President · Director | Sale | −25.0K | $3.68 | $92K | 6.0Mdirect | Feb 9, 2017 | Feb 10, 2017 | Form 4 ↗ |
| Murphy KeithChairman, CEO and President · Director | Sale | −20.1K | $3.50 | $70K | 6.0Mdirect | Jan 24, 2017 | Jan 25, 2017 | Form 4 ↗ |
| Murphy KeithChairman, CEO and President · Director | Sale | −4,900 | $3.51 | $17K | 6.1Mdirect | Jan 23, 2017 | Jan 25, 2017 | Form 4 ↗ |
| Murphy KeithChairman, CEO and President · Director | Sale | −50.0K | $3.72 | $186K | 6.1Mdirect | Dec 14, 2016 | Dec 15, 2016 | Form 4 ↗ |
| David EricCSO & EVP Pre-Clinical Dev | Sale | −20.0K | $4.55 | $91K | 706.3Kdirect | Aug 5, 2016 | Aug 9, 2016 | Form 4 ↗ |
| Baltera Robert Jr.Director | Sale | −6,000 | $4.03 | $24K | 138.5Kdirect | Sep 21, 2015 | Sep 23, 2015 | Form 4 ↗ |
| GLOVER JAMES TDirector | Purchase | +10.0K | $2.80 | $28K | 10.0Kdirect | Aug 13, 2015 | Aug 13, 2015 | Form 4 ↗ |
| Murphy KeithChairman, CEO and President · Director | Purchase | +20.0K | $2.56 | $51K | 5.9Mdirect | Aug 12, 2015 | Aug 13, 2015 | Form 4 ↗ |
| MICHAELS BARRY DChief Financial Officer | Sale | −10.5K | $7.50 | $79K | 285.6Kindirect | Dec 30, 2014 | Dec 31, 2014 | Form 4 ↗ |
| David EricChief Strategy Officer | Sale | −16.3K | $7.56 | $123K | 681.3Kdirect | Dec 30, 2014 | Dec 31, 2014 | Form 4 ↗ |
| MICHAELS BARRY DChief Financial Officer | Sale | −4,500 | $7.50 | $34K | 296.1Kindirect | Dec 29, 2014 | Dec 31, 2014 | Form 4 ↗ |
| David EricChief Strategy Officer | Sale | −3,700 | $7.50 | $28K | 697.7Kdirect | Dec 29, 2014 | Dec 31, 2014 | Form 4 ↗ |
| Presnell Sharon CollinsEVP, Research & Dev & CTO | Sale | −50.0K | $6.11 | $306K | 24.1Kdirect | Oct 6, 2014 | Oct 8, 2014 | Form 4 ↗ |
| David EricChief Strategy Officer | Sale | −30.0K | $7.30 | $219K | 701.3Kdirect | Sep 12, 2014 | Sep 16, 2014 | Form 4 ↗ |
| Renard MichaelEVP of Commercial Operations | Sale | −10.0K | $10.65 | $107K | 0direct | Feb 21, 2014 | Feb 21, 2014 | Form 4 ↗ |
| Murphy KeithChairman, CEO and President · Director | Sale | −100.0K | $9.82 | $982K | 6.0Mdirect | Feb 18, 2014 | Feb 20, 2014 | Form 4 ↗ |
| Renard MichaelEVP of Commercial Operations | Sale | −30.0K | $9.93 | $298K | 0direct | Jan 29, 2014 | Jan 29, 2014 | Form 4 ↗ |
| Renard MichaelEVP of Commercial Operations | Sale | −10.0K | $8.92 | $89K | 0direct | Jan 27, 2014 | Jan 29, 2014 | Form 4 ↗ |
| Murphy KeithChairman, CEO and President · Director | Sale | −100.0K | $10.86 | $1.1M | 6.1Mdirect | Jan 21, 2014 | Jan 23, 2014 | Form 4 ↗ |
| MICHAELS BARRY DChief Financial Officer | Sale | −85.4K | $9.07 | $774K | 502.8Kdirect | Dec 16, 2013 | Dec 18, 2013 | Form 4 ↗ |
| Murphy KeithChairman, CEO and President · Director | Sale | −100.0K | $10.08 | $1.0M | 6.2Mdirect | Dec 10, 2013 | Dec 12, 2013 | Form 4 ↗ |
| Murphy KeithChairman, CEO and President · Director | Sale | −100.0K | $9.64 | $964K | 6.3Mdirect | Nov 13, 2013 | Nov 15, 2013 | Form 4 ↗ |
| David EricChief Strategy Officer | Sale | −16.5K | $10.39 | $171K | 731.3Kdirect | Nov 13, 2013 | Nov 15, 2013 | Form 4 ↗ |
| Murphy KeithChairman, CEO and President · Director | Sale | −30.0K | $6.63 | $199K | 6.4Mdirect | Oct 18, 2013 | Oct 18, 2013 | Form 4 ↗ |
| Murphy KeithChairman, CEO and President · Director | Sale | −70.0K | $5.76 | $403K | 6.4Mdirect | Oct 16, 2013 | Oct 18, 2013 | Form 4 ↗ |
| David EricChief Strategy Officer | Sale | −3,530 | $5.66 | $20K | 747.8Kdirect | Oct 10, 2013 | Oct 15, 2013 | Form 4 ↗ |
| David EricChief Strategy Officer | Sale | −63.0K | $5.86 | $369K | 731.3Kdirect | Oct 7, 2013 | Oct 9, 2013 | Form 4 ↗ |
| Presnell Sharon CollinsEVP, Research & Dev & CTO | Sale | −75.0K | $5.64 | $423K | 74.1Kdirect | Oct 2, 2013 | Oct 4, 2013 | Form 4 ↗ |
| Presnell Sharon CollinsEVP, Research & Dev & CTO | Sale | −75.0K | $5.60 | $420K | 149.1Kdirect | Aug 12, 2013 | Aug 14, 2013 | Form 4 ↗ |
| MICHAELS BARRY DChief Financial Officer | Purchase Amended | +10.0K | $1.00 | $10K | 10.0Kdirect | Mar 16, 2012 | Jun 5, 2012 | Form 4 ↗ |
| MICHAELS BARRY DChief Financial Officer | Purchase | −10.0K | $1.00 | $10K | 10.0Kdirect | Mar 16, 2012 | Mar 20, 2012 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →